Company research
Renovacor, Inc.
CIK 1799850Updated Sep 26, 2026
Securities
Name history
Chardan Healthcare Acquisition 2 Corp. · through Sep 3, 2021Chardan Healthcare Acquisition III Corp. · through Jan 16, 2020
CHAQ price & chart
Historical security
This listing closed Sep 3, 2021. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 80,999,000Source | 86,965,161Source | 24,930Source |
| Property, Plant and Equipment, NetUSD | 379,000Source | 1,000Source | — |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 78,790,000Source | 687,313Source | 22,705Source |
| Assets, CurrentUSD | 80,553,000Source | 717,530Source | 24,930Source |
| Other Assets, NoncurrentUSD | 67,000Source | — | — |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 27,455,000Source | 859,438Source | 2,400Source |
| Stockholders’ equity: | |||
| Common Stock, Value, IssuedUSD | 2,000Source | 266Source | 500Source |
| Additional Paid in CapitalUSD | — | 5,782,977Source | 24,500Source |
| Retained Earnings (Accumulated Deficit)USD | -18,998,000Source | — | — |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | -783,240Source | -2,470Source |
| Stockholders' Equity Attributable to ParentUSD | 53,544,000Source | 5,000,003Source | 22,530Source |
| Additional Paid in Capital, Common StockUSD | 72,540,000Source | — | — |
| Liabilities and EquityUSD | 80,999,000Source | 86,965,161Source | 24,930Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 4,034,000Source | — | — |
| Accounts Payable, CurrentUSD | 1,536,000Source | — | — |
| Additional Financial Items | |||
| Accrued Liabilities, CurrentUSD | 2,498,000Source | — | — |
cash flow · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -14,101,000Source | -780,770Source | -520Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,373,000Source | — | — |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts PayableUSD | 1,346,000Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -15,560,000Source | -472,915Source | -2,295Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -20,000Source | -86,226,440Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 20,000Source | — | — |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 88,986,000Source | 87,363,963Source | 25,000Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 12,000Source | — | — |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | 1,373,000Source | — | — |
| DepreciationUSD | 2,000Source | — | — |
| General and Administrative ExpenseUSD | 6,872,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -14,101,000Source | -780,770Source | -520Source |
| Operating Costs and ExpensesUSD | — | 801,961Source | 520Source |
income statement · annual statements
| Line item | FY 2021 |
|---|---|
| Operating Income (Loss)USD | -18,629,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,101,000Source |
| Additional Financial Items | |
| General and Administrative ExpenseUSD | 6,872,000Source |
| Interest Income (Expense), NetUSD | -146,000Source |
| Research and Development ExpenseUSD | 11,757,000Source |